Vice President
Celldex Therapeutics
Vice President
Celldex Therapeutics
Develops antibody-based therapies targeting inflammatory diseases
Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. We have built a culture where innovative and talented people thrive—focusing a significant effort on attracting and retaining passionate and motivated employees who want to play a role in helping people with serious health conditions and who see this effort as personally rewarding. In our highly entrepreneurial environment, employees are empowered and the opportunity for professional development occurs every day.
The Vice President, Commercial Finance will build and lead Celldex’s Commercial Finance organization as the Company prepares for its first commercial launch and transitions from a clinical-stage biotechnology company to a fully integrated commercial biopharmaceutical organization.
Reporting to the Chief Financial Officer, the Vice President will serve as the senior Finance partner to Commercial leadership and will be responsible for the financial strategy, planning, forecasting, analytics and decision support required to successfully commercialize barzolvolimab and support future portfolio growth. This leader will build the capabilities, processes, systems and team required to support commercial financial planning and analysis, revenue forecasting, gross-to-net forecasting and analytics, pricing and contracting finance, government pricing finance, and trade and distribution finance.
The Vice President will partner closely with Commercial, Market Access, Pricing & Contracting, Trade & Distribution, Patient Services, Insights & Analytics, Supply Chain, Accounting and Corporate FP&A to ensure commercial strategies are supported by rigorous financial analysis and appropriately incorporated into the Company’s overall financial plan.
The ideal candidate is a strategic, hands-on Commercial Finance leader with significant biopharmaceutical launch experience and a demonstrated ability to build scalable finance capabilities in a growing organization. This individual will combine strong commercial and financial acumen with the ability to operate as a trusted business partner while maintaining appropriate financial discipline and stewardship.
This position is located onsite in Hampton, NJ
Commercial Finance Strategy & Leadership
Commercial Financial Planning & Analysis
Revenue Forecasting
Gross-to-Net Forecasting & Analytics
Pricing, Contracting & Trade Finance
Government Pricing Finance
Commercial Launch Readiness
Commercial Performance & Analytics
Cross-Functional Partnership
Team Leadership
Education
Experience
Develops antibody-based therapies targeting inflammatory diseases
Celldex Therapeutics develops antibody-based therapies for inflammatory, allergic, and autoimmune diseases, focusing on mast cell biology. Its lead program barzolvolimab is a humanized monoclonal antibody that inhibits KIT, reducing mast cell activity and inflammation; its pipeline includes other antibodies designed to engage the immune system or modulate disease pathways. The company leverages partnerships and licensing in addition to developing its own therapies to create a breadth of programs in its target areas. Its goal is to deliver therapies that lessen inflammation and autoimmune activity by targeting mast cells and related signaling pathways.
Explore more opportunities at Celldex Therapeutics